Click the play button below for a video of Brian Fairley

Company Profile

Johnson Matthey Pharma Services provides API outsourcing solutions throughout the drug development process, from early stage discovery services to commercial manufacturing. Located approximately 35 miles west of Boston, our facilities offer a design that incorporates both kilo-labs and pilot plant with expansion opportunity.

Strong cGMP and regulatory compliance underscores our services for custom synthesis, process development, scale-up, optimization, validation, and medicinal chemistry. Beyond traditional chemistry services, we can provide solutions for complex molecules by leveraging technologies within our site and the Johnson Matthey group.

These technologies include separation technologies (SMB, SFC, chiral separations, prep HPLC, etc.), asymmetric/chiral development, catalytic processes, and solid form screening. Our services are retained for a variety of compounds including small molecules, natural products (extraction), controlled drug substances, and highly potent active ingredients (HPAI). We are able to offer a wide range of manufacturing scale from grams to hundreds of kilograms. To round out these services, our regulatory department has an impeccable track record with PAI’s, FDA compliance audits, and provides CMC, IND, and NDA support to our client's regulatory filings.

Johnson Matthey Pharmaceutical Materials, Inc. (West Deptford, NJ & Conshohocken, PA) and Johnson Matthey Macfarlan Smith (Edinburgh, Scotland) round out the Pharma division with additional manufacturing capacity, core expertise in commercial API production, as well as extraction capabilities.

Whether you are a virtual biotech company, large pharmaceutical company or fall somewhere in between, our vast capabilities & services will enable you to quickly succeed in your discovery, development and production of API every step of the way.